Global health emergencies have a significant indirect impact on sexual and reproductive health and rights, by interrupting regular service provision, disrupting supply chains and information provision, and preventing women from accessing facilities to seek family planning and maternal care services.
Movement restrictions, supply chain disruptions and reduced health facility services associated with the COVID-19 pandemic are affecting women’s and adolescent girls’ sexual and reproductive health and rights needs, including access to safe abortion services. Self-managed medication abortion in early pregnancy is an established practice which has become increasingly important in response to COVID-19. As the FCDO (Foreign, Commonwealth and Development Office) WISH (Women’s Integrated Sexual Health) programme partners adapt their programmes to continue service provision during COVID-19, this Learning Brief summarises relevant learning from WISH partners and members of the wider SRHR community on self-managed medication abortion approaches during the pandemic. It is written by WISH4Results, the Third-Party Monitoring team for the FCDO WISH Programme.
Click here to read the learning brief